Login
$STRO
$8.87 -$0.02 (0.17%) Close

Company Executives

$STRO Management Team

Ms. Connie Matsui

Independent Chairman of the Board

Age 71
Compensation $181.4K USD
Sex Female

Ms. Jane Chung

President

Chief Executive Officer

Director

Age 54
Compensation $1.443M USD
Sex Female

Mr. Gregory Chow

Chief Financial Officer

Principal Accounting Officer

Age 52
Compensation -
Sex Male

Dr. Hans-Peter Gerber

Chief Scientific Officer

Age 62
Compensation $1.627M USD
Sex Male

Dr. Barbara Leyman

Chief Business Development Officer

Age 55
Compensation -
Sex Female

Dr. Venkatesh Srinivasan

Chief Technical Operations Officer

Age 63
Compensation -
Sex Male
Directors
8
serving now
Independent
7 of 7
stated in the proxy; 1 not stated
Average tenure
6.8 years
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards 2025 pay Source
Jane Chung
55 2025
1 year
Not stated None stated None stated Paid as CEO
James Panek
73 2020
6 years
Independent
Nominating and Governance Committee · Chair Science and Technology Committee
None stated $96,795
Heidi Hunter
67 2021
5 years
Independent
Audit Committee
Vicore Pharma Holding AB, Bavarian Nordic, IO Biotech $99,295
Jon Wigginton
64 2020
6 years
Independent
Compensation Committee Science and Technology Committee · Chair
None stated $100,295
Michael Dybbs
51 2018
8 years
Independent
Science and Technology Committee
Nkarta Therapeutics, Kalaris Therapeutics, Spyglass Pharma Not stated
Joseph M. Lobacki
67 2017
9 years
Independent
Audit Committee Compensation Committee · Chair
None stated $108,795
Daniel H. Petree
70 2009
17 years
Independent
Compensation Committee Nominating and Governance Committee
None stated $95,295
Sukhi Jagpal
52 2024
2 years
Independent
Audit Committee · Chair
None stated $99,295

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 22, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support